The invention is concerned with novel heteroarylacetamides of formula (I) R.sup.d--C(O)--N(R.sup.e)--R.sup.c--CH.sub.2--C(O)--N(R.sup.a)(R.sup.b) (I) wherein R.sup.a to R.sup.e are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit the coagulation factor Xa and can be used as medicaments.

 
Web www.patentalert.com

< Contortrostatin (CN) and methods for its use in preventing metastasis and other conditions

< Pyrrolo [3,4-H] isoquinoline compounds and methods for modulating gated ion channels

> Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase

> Isonipecotamides for the treatment of integrin-mediated disorders

~ 00608